期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
《内经》脾脉之我见 被引量:2
1
作者 汤川安 樊巧玲 《山东中医药大学学报》 2009年第3期194-195,共2页
《内经》对脾脉的描述,艰涩难懂,古代注释也多不尽如人意。经过分析研究认为:平脾脉之"如鸡践地",乃指柔和舒缓之脉;病脾脉之"如鸡举足",则指洪脉;死脾脉之"如鸟之喙、如鸟之距"当指革脉,"如屋之漏&... 《内经》对脾脉的描述,艰涩难懂,古代注释也多不尽如人意。经过分析研究认为:平脾脉之"如鸡践地",乃指柔和舒缓之脉;病脾脉之"如鸡举足",则指洪脉;死脾脉之"如鸟之喙、如鸟之距"当指革脉,"如屋之漏"是指迟怠脉或结脉",如水之流"则指极快速脉。 展开更多
关键词 内经 病脾脉 基础理论研究
下载PDF
《脾胃论》辨治迟脉症探幽
2
作者 马英明 田静峰 《中医临床研究》 2023年第29期34-38,共5页
文章首先从《黄帝内经》中总结寸口脉与脾胃的生理机制关系,进而从《脾胃论》中摘取相关内容,阐述李杲(号东坦)认为脾胃病是迟脉症病因的观念。脉象在临床上确立了脾胃不足型、心火亢盛型、肝木妄行型、肺金受邪型以及肾水反来侮土型等... 文章首先从《黄帝内经》中总结寸口脉与脾胃的生理机制关系,进而从《脾胃论》中摘取相关内容,阐述李杲(号东坦)认为脾胃病是迟脉症病因的观念。脉象在临床上确立了脾胃不足型、心火亢盛型、肝木妄行型、肺金受邪型以及肾水反来侮土型等五种类型,脉象分别为迟缓脉、兼洪大、兼弦、兼浮涩、兼沉细。文章着重体现其在证候归纳、病机分析、选方用药等方面的理论,介绍其纳入运气理论来总结脾胃病与其他四脏盛衰的规律,依据升降浮沉的机制进行分类选药的思想,形成从脾胃论治迟脉症的理论体系,并列表加以说明。通过列举一例肾水反侮证型迟脉症病例进行探讨,用干姜为君,白术、附子配合,从脾胃以壮中阳,上可温补心肺以增御外之力,下可坚肝肾以治寒湿痿厥,故新病久病俱适用,从实践阐述其理论精要,并在选方用药上与麻黄附子细辛汤相比较以说明其优势。 展开更多
关键词 升降浮沉
下载PDF
2型糖尿病合并多并发症案1例——仝小林院士教学查房实录 被引量:1
3
作者 高胜男 蔡洁超 +3 位作者 田佳星 王涵 吴学敏 朴春丽 《长春中医药大学学报》 2024年第7期709-712,共4页
仝小林院士倡导糖尿病单元化管理模式治疗糖尿病多并发症,更大程度发挥医院多学科团体的力量,更系统地为患者诊疗。以广州中医药大学深圳医院(福田)内分泌科中1例糖尿病合并多并发症患者为例,邀请仝小林院士进行教学查房,对此类患者的... 仝小林院士倡导糖尿病单元化管理模式治疗糖尿病多并发症,更大程度发挥医院多学科团体的力量,更系统地为患者诊疗。以广州中医药大学深圳医院(福田)内分泌科中1例糖尿病合并多并发症患者为例,邀请仝小林院士进行教学查房,对此类患者的中医辨治思路、疾病发展、诊疗要点进行阐述。强调《黄帝内经》对肥胖类型的阐述及对其辨别的重要性,把握疾病发展的过程,运用态靶辨治体系,结合慢病十态处方,减少西药的使用,提高患者生活质量。 展开更多
关键词 瘅-络 多并发症 态靶辨治 络并治
下载PDF
Splenic arteriovenous fistula and sudden onset of portal hypertension as complications of a ruptured splenic artery aneurysm: Successful treatment with transcatheter arterial embolization. A case study and review of the literature 被引量:6
4
作者 Dimitrios Siablis Zafiria G Papathanassiou +3 位作者 Dimitrios Karnabatidis Nikolaos Christeas Konstantinos Katsanos Constantine Vagianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第26期4264-4266,共3页
Splenic arteriovenous fistula (SAVF) accounts for an unusual but well-documented treatable cause of portal hypertension. A case of a 50-year-old multiparous female who developed suddenly portal hypertension due to S... Splenic arteriovenous fistula (SAVF) accounts for an unusual but well-documented treatable cause of portal hypertension. A case of a 50-year-old multiparous female who developed suddenly portal hypertension due to SAVF formation is presented. The patient suffered from repeated episodes of haematemesis and melaena during the past twelve days and thus was emergently admitted to hospital for management. Clinical and laboratory investigations established the diagnosis of portal hypertension in the absence of liver parenchymal disease. Endoscopy revealed multiple esophageal bleeding varices. Abdominal computed tomography (CT) and transfemoral celiac arteriography documented the presence of a tortuous and aneurysmatic splenic artery and premature filling of an enlarged splenic vein, findings highly suggestive of an SAVF. The aforementioned vascular abnormality was successfully treated with percutaneous transcatheter embolization. Neither recurrence nor other complications were observed. 展开更多
关键词 Splenic artery aneurysm Splenic arteriovenous fistula Portal hypertension Transcatheter embolizaUon
下载PDF
Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C 被引量:5
5
作者 Lena Sibulesky Justin H Nguyen +2 位作者 Ricardo Paz-Fumagalli C Burcin Taner Rolland C Dickson 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第40期5010-5013,共4页
Hepatitis C is the most common indication for orthotopic liver transplantation in the United States. Unfortunately, hepatitis C recurs universally in the transplanted liver and is the major cause of decreased graft an... Hepatitis C is the most common indication for orthotopic liver transplantation in the United States. Unfortunately, hepatitis C recurs universally in the transplanted liver and is the major cause of decreased graft and patient survival. The combination therapy of interferon and ribavirin has been shown to be the most effective therapy for recurrent hepatitis C. However, pre-and post-transplant hypersplenism often precludes patients from receiving the antiviral therapy. Splenectomy and partial splenic embolization are the two invasive modalities that can correct the cytopenia associated with hypersplenism. In this report we review the two treatment options, their associated outcomes and complications. 展开更多
关键词 HYPERSPLENISM LEUKOPENIA Recurrenthepatitis C THROMBOCYTOPENIA Liver transplant
下载PDF
EXPERIMENTAL STUDY ON THE SEGMENTAL PERFUSION AND PRESERVATION OF SPLEEN
6
作者 侯利民 姜洪池 +2 位作者 代文杰 乔海泉 许军 《Chinese Medical Sciences Journal》 CAS CSCD 1999年第4期242-245,共4页
Objective. Spleen transplanlation has developed to be an effective strategy for hemophilia A. But it has not been reported up to date that which kind of established solutions is most suit... Objective. Spleen transplanlation has developed to be an effective strategy for hemophilia A. But it has not been reported up to date that which kind of established solutions is most suitable for perfusion and preservation of spleen. This study aimed to establish some experiences with the comparison among Hartmann’s solution, Collins’ solution and WMO I solution, in order to instruct the clinical spleen transplantation. Methods. After the splenic artery and vein were dissociated clearly, three kinds of perfusion solutions began to perfuse the corresponding segments of spleen with a randomized sequence. When the efferent fluids from the splenic vein became clear, the perfused spleen segments were preserved for different durations with the same perfusing solution to calculate the survival rate of splencocyte(SRS) and were examined with light and electron microscopy. Results. Among the three solutions, SRS with WMO I solution was significantly higher than those of the other two(P< 0.001). The perfused spleen with WMO I solution showed the slightest morphological changes and a significant longer preservation duration than those with the other two(P<0.05 or P< 0 01). Conclusion. Among the three solutions, WMO I solution was most suitable for perfusion and preservation of spleen. 展开更多
关键词 SPLEEN perfusion solution preservation solution
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部